Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) insider Benjamin T. Dake sold 12,517 shares of the stock in a transaction on Monday, November 27th. The shares were sold at an average price of $16.24, for a total value of $203,276.08. Following the sale, the insider now directly owns 1,291 shares in the company, valued […]
Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) insider Benjamin T. Dake sold 9,382 shares of the firm’s stock in a transaction dated Wednesday, November 22nd. The shares were sold at an average price of $15.17, for a total value of $142,324.94. Following the transaction, the insider now owns 1,291 shares in the company, valued […]
Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) CTO Marinus Verwijs sold 970 shares of the firm’s stock in a transaction dated Wednesday, November 1st. The shares were sold at an average price of $10.46, for a total value of $10,146.20. The transaction was disclosed in a filing with the SEC, which is accessible through […]
Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Free Report) – Stock analysts at Wedbush dropped their Q3 2023 earnings per share (EPS) estimates for shares of Aerovate Therapeutics in a research report issued to clients and investors on Tuesday, August 15th. Wedbush analyst A. Argyrides now expects that the company will post earnings of ($0.65) per share […]